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Non-communicable diseases account for more than 50% of deaths in adults aged 15–59 years in most low income
countries. Depression and diabetes carry an enormous public health burden, making the identification of risk factors
for these disorders an important strategy. While socio-economic inequalities in chronic diseases and their risk
factors have been studied extensively in high-income countries, very few studies have investigated social
inequalities in chronic disease risk factors in low or middle-income countries. Documenting chronic disease risk
factors is important for understanding disease burdens in poorer countries and for targeting specific populations for
the most effective interventions. The aim of this review is to systematically map the evidence for the association of
socio-economic status with diabetes and depression comorbidity in low and middle income countries. The
objective is to identify whether there is any evidence on the direction of the relationship: do co-morbidities have
an impact on socio-economic status or vice versa and whether the prevalence of diabetes combined with
depression is associated with socio-economic status factors within the general population. To date no other study
has reviewed the evidence for the extent and nature of this relationship. By systematically mapping the evidence in
the broader sense we can identify the policy and interventions implications of existing research, highlight the gaps
in knowledge and suggest future research. Only 14 studies were found to analyse the associations between
depression and diabetes comorbidity and socio-economic status. Studies show some evidence that the occurrence
of depression among people with diabetes is associated with lower socio-economic status. The small evidence base
that considers diabetes and depression in low and middle income countries is out of step with the scale of the
burden of disease.Background
Global burden of diabetes, depression and comorbidities
Diabetes causes 4.6 million deaths per year, accounting
for 8.2% of global all-cause mortality, and it is estimated
that 366 million adults have diabetes [1]. The global
mortality burden of diabetes is not evenly distributed,
with low and middle income countries carrying a dispro-
portionate burden. It is projected that by 2030 around
82.5% of people with diabetes will live in developing
countries [1]. The age distribution of adults with dia-
betes differs by country.
The occurrence of depression appears to be linked
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reproduction in any medium, provided the orthe physician who first identified glycosuria as a sign of
diabetes, suggested that diabetes resulted from ‘sadness
or long sorrow and other depressions or disorders’ [2].
Further studies have demonstrated that a comorbid state
of depression incrementally worsens health compared
with depression alone [3]. According to the latest global
burden of disease estimates unipolar depressive disorder
are third in the ranking (65.5 mil DALY worldwide of
which 26.5 in LICs). Unipolar depressive disorders are
set to become the leading disease in 2030 with 6.3% of
the overall burden and Diabetes the 10th place with 2.3%
as a percentage of the overall DALYs [4].
Comorbidity has various definitions and previous lit-
erature has highlighted the difficulty of defining it but in
general, in medicine, it is usually considered as the pres-
ence of one or more disorders (in addition to a primarytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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disorders or diseases [5]. In this study we look at the co-
presence of diabetes and depression regardless of
whether diabetes or depression is the primary disorder.
The identification of co-morbidities is fundamental in
order to understand whether the primary disorder or
disease might either cause or affect the secondary one
but also to understand any association between the two.
Studies have scrutinized the association of diabetes
with depression and the bidirectional nature of this rela-
tionship; considering that depression may occur as a
consequence of having diabetes, but may also be a risk
factor for the onset of type 2 diabetes a [6-8]. One study
showed how there is a higher risk of mood and anxiety
disorders among individuals with diabetes relative to
those without, with an odds ratio for depression of 1.38
(95% CI 1.14-1.66) after adjusting for age and gender [9].
A meta-analysis concluded that the presence of diabetes
doubles the odds of comorbid depression and the
prevalence of comorbid depression among people with
diabetes was 11% [10]. Estimates of depression preva-
lence among people with diabetes appear to vary by
diabetes type and between lower and higher income
countries, although the evidence base for lower income
countries is much smaller than that for HICs [11]. A
study conducted in 2007 which looked at depression
worldwide using the WHO World Health Survey
(WHS) found that 9.3% of people with depression were
also with diabetes [3].
Two hypotheses attempt to explain the causal pathway
between diabetes and depression. One hypothesis asserts
that depression precedes type 2 diabetes, with depres-
sion occurring as a result of increased counter regulatory
hormone release and action, alterations in glucose trans-
port function and increased immuno-inflammatory acti-
vation. These physiologic alterations are thought to
contribute to insulin resistance and beta islet cell dys-
function, leading to development of type 2 diabetes [12].
The second hypothesis is that depression in patients
with both type 1 and type 2 diabetes results from
chronic psychosocial stressors of having a chronic med-
ical condition [13].
Evidence from HICs suggests that depression among
people with diabetes is associated with socio-economic
status [14], marital status [15], and physical activity and
chronic somatic diseases [16]. Psychosocial factors may
mediate the relation between SES and depression in
people with diabetes, including social isolation or social
support, coping styles, behaviour and job stress or strain
[17,18]. Most studies show inverse social gradients,
meaning that the risk is higher for people with lower
SES [14-16,19]. However, the relationship may vary de-
pending on the social and economic context of the
country. In LICs, higher SES may be associated withhigher levels of chronic disease risk factors in general
[20] while the poor experience a double burden of infec-
tious and chronic diseases according to the protracted
polarised model of epidemiological transition [21].
In addition, the burden of risk factors for depression
among people with diabetes in particular has been found
to shift towards the less affluent in countries undergoing
the epidemiologic transition where the cause of deaths
shifts from infectious to non-infectious causes [22].
The aim of this systematic mapping is to identify the
socio-economic factors associated with diabetes and de-
pression as a comorbid condition exclusively in low and
middle income countries.
Methodology
We systematically mapped the evidence pertaining to
poverty and depression-diabetes comorbidity in low and
middle income countries. We searched 12 databases b,
selected for their coverage of the behavioural and social
sciences, using combinations of keywords (diabetes, dia-
betes mellitus, chronic disease, depression, depressive
disorder), and individual countries defined as low or
middle income. The search included items written in
English and with an abstract dated 1990–2011 and was
completed in August 2011. Studies were also identified
by hand-searching reference lists of reviews and articles
found in the database search. We used broad search
terms in order to include the widest literature possible
in our mapping. This means that we not only identified
items where the authors had measured or defined SES,
but we also included items which considered variables
often used as proxies for SES (e.g.: education, unemploy-
ment). The search was limited to studies published after
1989 and we identified 1747 relevant articles (Table 1).
Systematic mapping is a transparent technique for de-
scribing the research evidence on a topic. It not only
allows us to take stock of the available research, but also
to identify the gaps in the evidence base and how it
might be developed [24]. The methodology for system-
atic mapping developed from work at the EPPI-Centre
(Evidence for Policy and Practice Information and Co-
ordinating Centre) and is being increasingly used in a
range of social sciences [25-28]. The type of evidence
and scope included in a systematic mapping is broader
than that normally included in a systematic review,
reflected in the breadth of the research questions. A sys-
tematic mapping can be much more inclusive [25-28] in
its selection of studies than a systematic review can be.
Inclusivity benefits the evidence base by assembling evi-
dence in a systematic way. As a systematic mapping, ra-
ther than a systematic review, we have not assessed the
quality of the included studies. This means that the evi-
dence base that we have identified is not necessarily all
of high quality.
Table 1 Studies (n = 14) included in the mapping
Author Year of
publication
Sample
size
Country
of study
Association with
SES
Recommended intervention Clinical
assessment
Analysis
Agbir 2010 160 Nigeria No significant
association
between patients
with diabetes and
depression and
SES
Screen people with diabetes
for depression especially those
at “high risk” (e.g.: unmarried
females); increase patient
compliance to treatment,
prevent complications, improve
quality of life.
Clinical
assessment of
depression
and blood
glucose
Association of depression with
newly diagnosed type 2
diabetes among adults
Eren 2008 108 Turkey Negative
correlation with
SES (education)
Early detection and treatment
of depression in people with
diabetes.
Clinical
assessment of
depression
and blood
glucose
Impact of depression on
diabetic quality of life.
James 2010 400 Nigeria SES(Education,
occupation,
income)
Screening for depression
among people with diabetes
and management of
depression to improve quality
of life and reduce treatment
costs
Questionnaire
and blood
glucose
Prevalence of depression and
SES
Kilzieh 2008 2038 Syria Comorbidity
decreases with
increasing SES
Deliver treatment for
depression in primary care
settings because access to
mental health services are
limited and stigmatised.
Questionnaire
and diabetes
self-reported
assess the comorbidity and
correlates of depression in
chronic diseases in a
community
Mansour 2007 103, 103 Iraq SES(Education,
occupation,
income)
None made Questionnaire
and blood
glucose
Determine the prevalence of
comorbid depression among
sample of patients with type 2
diabetes mellitus. Control for
social class
Mier 2008 200 Mexico
and USA
Low education
increases risk of
depression
Depression screening among
diabetic patients by family
practice physicians.
Questionnaire
and diabetes
self-reported
prevalence and correlates of
clinical depressive symptoms in
Hispanics of Mexican origin
with type 2 diabetes
Pan 2008 3285 China Low education
level and presence
of co-morbidities
associated with
depressive
symptoms
None made Questionnaire
and blood
glucose
Association between insulin
resistance and depressive
symptoms
Raval 2010 300 India Relationship
between
comorbidity and
income and
education unclear
None made Questionnaire
and blood
glucose
Prevalence and determinants
of depression in patients with
established type 2 diabetes
(T2DM)
Sevincok 2001 98 Turkey Failed to find
association
between
None made Clinical
assessment
and blood
glucose
Assess association of socio-
demographic variables for
patients with and without
comorbidity
Tellez-
Zenteno
2002 189 Mexico Higher risk of
depression for
lower SES
Screen for depression in all
diabetic patients, so that early
diagnosis and treatment can
improve patient metabolic
control and enhance patient
quality of life.
Clinical
assessment
and blood
glucose
Identify the prevalence and
factors associated with
depression in a group of
patients with type 2 diabetes
mellitus
Thaneerat 2009 250 Thailand Association for co-
morbid patients
not clear
Early detection of depression
among diabetic patients
self-reported
questionnaire
and blood
glucose
To estimate the prevalence of
depression, and poor glycemic
control, and to determine the
associated factors in
outpatients with type-2
diabetes.
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Table 1 Studies (n = 14) included in the mapping (Continued)
Yang 2009 148 China Not clear Early detection and treatment
of depression in people with
diabetes by community nurses
and provision of social support.
Self-reported
Questionnaire
and diabetes
self-reported
To examine levels of perceived
social support and depression
and to identify the related
factors and
Yekta 2010 295 Iran Lower educated
higher risk of
depression
None made Self-reported
questionnaire
and blood
glucose taken
To describe the prevalence of
depression in patients
attending a diabetes clinic
determine the associated
sociodemographic, behavioural
and clinical factors.
Zhang
CX
2008 304 China Not clear Identify source of patient stress;
Advise on active coping styles;
Mobilize more social support
resources to reduce risk of
depression in Type 2 diabetes.
Clinical
assessment
and blood
glucose
To investigate association of
psychosocial factors with
anxiety and depressive
symptoms in type 2 diabetes
patients
Depression is responsible for the greatest proportion of disease burden associated with non-fatal health outcomes, accounting for approximately 12% of the total
years lived with disability [4]. The evidence base and data for LICs are under-developed, but it is estimated that the average lifetime and 12-month prevalence
estimates of major depression episodes was 11.1% and 5.9%, respectively, on the basis of data from eight LMICs [23].
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Abstracts were screened and items included if they
addressed diabetes (type 2 or type 1 and 2 together to
keep the disease type homogeneous), and depression as
a comorbidity with diabetes, and SES. Studies were
excluded if: they were conducted exclusively in HICs;
did not address SES as a risk factor or consequence; the
full-text was not in English; the study population was
aged below 16 years; and, if there was no abstract.Defining and measuring SES
Our search strategy was deliberately inclusive in order to
map the available evidence as widely as possible. Reflect-
ing the different approaches to conceptualising socio-
economic status are the indicators used to measure it.
Rather than considering just one term such as “poverty”,
we considered socio-economic status (SES) in general,
including both individual-level (e.g.: education, occupa-
tion, income, household assets, place of residence, age,
marital status, family type and social support) and
household-, family- and community-level characteristics.
Debates about conceptualising, defining and operational-
izing socio-economic status are well-established and be-
yond the scope of this systematic mapping [29-34].
Characteristics of communities or neighbourhoods,
such as the availability and accessibility of health ser-
vices, infrastructure deprivation, prevailing attitudes
towards health, levels of stress and social support,
and environmental conditions, may influence general
health outcomes [35]. The socio-economic status of a
community may determine the educational, employ-
ment, and income opportunities of individuals and
may also directly influence the social environment, al-
though it is subject to the ‘ecological fallacy’ of as-
suming that all individuals in an area have similar
characteristics [36].Defining and assessing depression and diabetes
Measurement of depression usually relies on structured
interviews conducted by a professionally trained clin-
ician or nursing staff using established criteria to identify
a cluster of symptoms that may accompany depression
(e.g.: loss of interest or pleasure in everyday activities,
lack of appetite, fatigue, sleep disturbances, suicidal idea-
tion). Most tools used to identify and rate the severity of
depression rely on a multiple choice questionnaire, for
example, The Hamilton Rating Scale for Depression
(HRSD, HAM-D) the MINI questionnaire, the Beck
Depression Inventory (BDI) [37]. It should be noted,
however, that in many LICs lack the resources – both
human and financial – to detect depression [38].
Similar problems of detection and diagnosis affect the
valid measurement of diabetes in LICs Diabetes can be
identified by either clinical blood glucose measurements,
although some studies use “self-reported diagnosis” asso-
ciated with diabetes. Self reports of diagnosis tend to be
used in settings where glucose data are unavailable, and
cannot distinguish between Type 1 and Type 2 diabetes.
It is important to note that self-report might underesti-
mate type 2 diabetes due to undiagnosed cases [11].
Results
The search yielded 1,747 items, of which 1647 were
excluded after abstract screening. Of the remaining 100
items, the full text via institutional (London School of
Economics) access was only available for 63 studies, of
which a further 11 were excluded because the full-text
was not in English. Where full-text institutional access
was not available, we used secondary databases (e.g.:
Google Scholar) to try to retrieve full text of the
remaining 37 items but none were available through this
route. Most non-retrievable items were unpublished
working papers with abstracts that were identified by the
search, but not available electronically. The remaining
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review of their full text, after which a total of just 14
studies were selected for inclusion in the mapping. The
main reason for exclusion at this stage was that an asso-
ciation between depression-diabetes comorbidity and
SES was not sought or diabetes and depression cases
were considered as separate diseases in two different
populations rather than as a comorbidity (e.g.: diabetic
patients with depression or viceversa) in a specific group
of people.
Description of included studies
All the 14 included studies were published post-2007,
reflecting the nascent interest in depression-diabetes
comorbidity in LICs. All of the included studies were
cross sectional in design, and we did not identify any
longitudinal or intervention studies, meaning that causal
inference was not a possibility in our mapping. Just five
studies [39-43] used a control case design to compare
diabetic patients with and without depression. Three
studies were community-based [43-45] while the rest
where facility-based. It is important to separate facility-
and community-based studies in order to take account
of bias (Berkson’s bias), as barriers to accessing health
care might bias results from facility based studies be-
cause they are more likely to include patients: from
higher socio-economic strata; with more advanced dis-
ease; and, more likely to have another comorbid disorder
than those in the general population [46].
Facility-based studies tended to have relatively small
(at most n = 400) sample sizes and were carried out at
tertiary hospitals, which in LICs might be more likely to
cater for patients from higher socio-economic strata and
with more advanced disease. This difference needs to be
taken into account when making statements about true
population differences, which might account for incon-
sistencies in association between socio-economic status
and diabetes-depression comorbidity across studies.
Studies which used control groups for comparison were
not always clear about the characteristics of the control
groups which could have potentially affected the effect
of sample sizes on the overall results.
Of the facility-based (n = 11) studies, 4 studies had a
control group, although they differed in control group
selection [39-41,43,47]. A study from Nigeria recruited
diabetic patients as cases and apparently healthy controls
without a history of diabetes mellitus from local govern-
ment staff of three local government areas [40]. A simi-
lar approach was used in a study from Iraq, which
compared diabetic patients (case) with healthy controls
drawn from hospital staff [41]. A study conducted in
Turkey recruited diabetic patients and assessed them for
presence of depression [39]. Finally, [42] assessed the
prevalence of depression in Hispanics of Mexican originwith type 2 diabetes living on both sides of the Texas-
Mexico border, recruiting people with type 2 diabetes
from clinical settings which included hospitals and phy-
sicians’ offices on both sides of the border.
Assessing socio-economic status
The operationalization and definition of SES in studies
included in our mapping are heterogeneous. There is lit-
tle or no discussion about the validity or reliability of the
many difference measures of, and proxies for, SES. Stud-
ies that cautiously and robustly identify the presence of
diabetes and depression comorbidity tend not to apply
the same rigour to SES and its measurement. SES indi-
cators in studies included in our mapping include indi-
cators at a variety of scales, including individual and
household.
Employment and education were the most frequently
used variables to assess SES. Most studies included edu-
cation as a proxy of SES [39-42,48-53]. Categorisations
varied from literate-illiterate dichotomy [48,52] to years
of education [40,50,51]. Employment was considered as
a dichotomy (employed vs. unemployed) [40,48]. Three
studies used income [40,41,52], and just one study used
place of residence [52] to represent SES.
Finally, three studies used composite indicators of SES
[44,53-55]. For example, a study from Syria assigned a
score for SES based on work status, number of earning
members within a household, household income, educa-
tion level, item ownership and household density (num-
ber of individuals living in the household divided by the
number of rooms) [44].
Studying comorbidities: diabetes and depression
No study sought a causal relationship between SES and
diabetes-depression comorbidity. The majority of studies
considered the risk of, and risk factors for, depression
in diabetic patients. Two community-based studies
addressed diabetes and depression as a comorbidity –
hereafter referred to as “direct diagnosis of comorbidity”
[44,45]. The Kilzieh study [44] assessed the comorbidity
of depression with other chronic diseases in a single
Syrian city, using two stage, stratified cluster sampling,
with a sample size of 2038. The second study, from
China, was community based and conducted among
people with type 2 diabetes (n = 148) and assessed the
association between diabetes and depression comorbidity
with SES [45].
The remaining studies looked at depression risk in
patients with diabetes, hereafter referred to as “indirect
diagnosis of comorbidity” because the comorbidity was
assessed indirectly by considering the patient’s risk of
depression. A notable finding, which helps to explain the
lack of studies in the area of diabetes and depression
comorbidity, is that in studies conducted at geriatric or
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chronic medical conditions, patients were often diag-
nosed with psychiatric comorbidity only as a result of
going to the clinic. This suggests that there is a substan-
tial burden of undiagnosed psychiatric disorders, includ-
ing depression [48,50,51,53,54,56].
Direct diagnosis of comorbidities and their relationship
with SES
The study by Kilzieh [44] in Syria showed that depres-
sion comorbidity with any chronic disease decreased
with higher SES (middle vs. low: OR = 0.41, 95% CI:0.22-
0.78; high vs. low: OR = 0.52, 95% CI:0). An increase in
comorbid depression in women with lower SES under-
lines the higher vulnerability of women to adverse men-
tal health effects of lower SES. This relationship was not,
however, confirmed in the relationship with education
where a significant increase in depression comorbidity
was reported in those with 1–9 years of education,
which, according to the authors, may reflect ascertain-
ment bias. That is, more educated individuals are more
likely to seek medical care and consequently to be diag-
nosed with depression and chronic disease. This study
also considered other proxies for SES, including the
community-level proxy of place of residence, and found
depression to be associated with disadvantaged neigh-
bourhoods or “informal zones” (OR = 0.22, 95% CI:0.06-
0.80) in the Kilzieh study [44]. Informal zones are areas
in which houses were built without government ap-
proval, reflecting disadvantaged status.
Unemployment was significantly associated with de-
pression in diabetic patients in the study by Yang [45].
At household levels, those with low income, less wealthy
or those with fewer household assets were more likely to
be depressed [44]. Finally, lower levels of social support
were significantly associated with depression in the study
by Yang [45] using a multidimensional scale of perceived
social support.
Indirect diagnosis of comorbidity and its relationship
with SES
Socio-economic indicators at the individual level (e.g.: un-
employment, education) were associated with depression
in these studies that indirectly diagnosed depression-
diabetes comorbidity [22,45,57].
A study from China found no significant difference in
depressive symptoms between rural and urban dwellers
(p = 0.129) [49]. This study was conducted in one rural
county and two urban districts in two geographical loca-
tions of Beijing and Shanghai, which might account for
the lack of an observed statistical difference because of
the predominance of an urban population. However, this
study did note a statistically significant association for
women (but not men) between depressive symptomsand insulin resistance (OR 1.58, CI 1.14-2.18; P = 0.006)
after adjusting for geographic location, residential region,
age, educational level, smoking and drinking status,
physical activity level, BMI category and comorbidity. By
contrast, no significant association between depression
comorbidity with place of residence was found in studies
from Nigeria (p = 0.80) [48] and India (OR 0.76, CI 0.44-
1.34, p = 0.35) [52]. Both studies were carried out in ter-
tiary health care facilities, meaning that their samples
tended to involve complicated cases, not necessarily rep-
resentative of a true population difference.
Mansour et al.’s [41] Iraq study derived an indicator
for “social class” based on an aggregate score of educa-
tion, occupation and income. The control group had a
higher social class than patients with diabetes, which
could be explained by the recruitment of controls from
the medical staff of the hospital.
Monthly income for diabetic patients was significantly
and negatively correlated with depression scores in a
study from Nigeria [40] (Pearson coefficient(r) = −0.207,
p = 0.003). Similar findings are found from research in
Iran which reported that depressed patients were poorer
(64.1% vs. 52.4% had a low income level, p < 0.05) [53].
A decline in economic condition was significantly asso-
ciated with depression among people with diabetes in a
study from China using multiple regression analysis with
adjustment for sex, age, marital status, educational level,
income, employment, years since diagnosis of disease,
and presence or absence of diabetes complications. (Beta
0.482, t value 2.059, p = 0.041 and partial correlation
0.132.) [54,55]. By contrast, in India depression comor-
bidity was significantly associated with high monthly in-
come (OR 1.22, CI 1.03-1.41, P < 0.001) [52]. Finally, no
significant association with monthly income and depres-
sion comorbidity was found in the Agbir study (P =
0.110) from Nigeria [48].
Drawing conclusions about the relationship between
education and depression-diabetes comorbidity is diffi-
cult because of the highly heterogeneous ways in which
education was conceptualised across the different stud-
ies, in part reflecting different education systems be-
tween countries. The majority of studies found no
significant association between the depression comorbid-
ity and education level for a range of countries including
Nigeria (Chi-square 1.229, df = 1, P = 0.268) [48]; India
[52] (literate vs. illiterate, OR 1.12; CI 0.93-1.46, P = 0.07).
Studies that compared depressive and non-depressive
groups also showed no significant difference in Nigeria
(Chi-square = 0.705, P = 0.343) [40] and Turkey (t = 1.31,
P > 0.05) [39] and (r = −0.07, P = 0.49) [43].
The remaining four studies all suggest that lower edu-
cation is associated with depression among people with
diabetes, including: education up to secondary was sig-
nificantly associated with depression among people with
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people with diabetes who had <5 years of education
were more likely to be depressed (OR 3.26, CI 1.57-6.80,
p = 0.0004) [50]. Diabetic patients in Thailand with less
than 12 years education were significantly more likely to
be depressed (OR 2.33, 1.28-4.29, p < 0.01) [51]. Finally,
depressed patients were less educated than non-depressed
patients in an Iranian study (OR 4.20 CI 1.10-5.60;
p < 0.0001) [53].
Considering the relationship between employment, as
a proxy for SES, and the comorbidity the findings are
equally mixed. Three out of five studies found no signifi-
cant association between depression-diabetes comorbid-
ity and employment, including studies from Malaysia
(Chi-square = 0.429, p = 0.512) [47] and Nigeria (Chi
square = 0.04, df = 1, P = 0.84) [48] and (Chi-square =
0.087, P = 0.445) [40]. Of the two studies, both from
Mexico, which did find a relationship between employ-
ment status and depression-diabetes comorbidity both
report the same direction: lower employment status was
significantly associated with depression among people
with diabetes [42,50].
Poorer levels of social (including family) support
were significantly associated with depression among
people with diabetes studies from Thailand (OR 4.10,
CI 1.78-9.53, p < 0.01) [51] and Mexico (OR 2.79, CI
1.02-7.82, p = 0.02) [50]. Depressive symptoms were
negatively correlated with subjective social support in
China (Beta −0.162, t = −3.635, p = <0.000 and partial
correlation −0.228) [54,55].
Study limitations
There are limitations of our search strategy that have
implications for the scope of included evidence. Firstly,
we only included items with English abstracts, meaning
that we are likely to have excluded from the mapping
substantial research evidence which may be of relevance
for this topic. We did, however, review the type and con-
tent of these non-English items on the basis of their title
and abstract only. Among these studies, only three stud-
ies, all from Latin America, appeared to be relevant to
our study. A study from Brazil concludes that among
people with diabetes, higher education, low family and
individual income predispose to symptoms of depression
[58]. A study in Mexico concludes that among people
with type 2 diabetes, significant differences between
depressed and non-depressed participants were found in
schooling, marriage type and occupation [59]. A study
assessing trends in social and demographic inequalities
in the prevalence of chronic diseases including diabetes
and depression in Brazil [60] revealed a higher presence
of chronic diseases in low socio-economic strata. The
remaining non-English studies did not provide sufficient
evidence in their abstract for us to describe them here[61-66]. Secondly, we excluded studies that consider dia-
betes and depression in low and middle income coun-
tries that did not explicitly include reference to SES or
one of its proxies. Therefore, there are themes that are
potentially linked with the pathways between SES and
diabetes and depression that we have not explored in
this mapping, which may further our understanding of
the relationship. A third limitation is methodological. As
a systematic mapping, rather than a systematic review,
we have not assessed the quality of the included studies.
This means that the evidence base that we have identi-
fied is not necessarily all of high quality. However, as a
systematic mapping we set out to describe the available
research in order to show the gaps in the literature and,
by taking an inclusive approach to our search, we have
identified studies of research and policy relevance.
Fourth, studies that failed to find any significant rela-
tionship between depression and diabetes as a comor-
bidity and SES, might not be published, introducing the
possibility of publication bias. However, this possibility is
diminished by the fact that we did find, but did not in-
clude studies in which diabetes and depression comor-
bidity was not the principle focus of interest of many of
the included studies and that depression was reported as
the commonest psychiatric disorder while diabetes was
one of the many chronic disorders in the populations
under study [56]. Fifth, assessment of SES is heteroge-
neous, limiting statistical comparability. Sixth, we
included studies that used self-reports of diabetes, mean-
ing there is no differentiation between type 1 and type 2
diabetes. There are further limitations linked to our ana-
lysis which are due to the quality and quantity of the
papers found. Given the heterogeneity of the SES indica-
tors and the small number of studies found we could
not perform either a meta-analysis or a causal chain ana-
lysis. Finally, our inability to electronically retrieve 37
full text items, identified on the basis of our abstract
search, means that we were unable to review some po-
tentially relevant items. The majority of these items were
non-peer-reviewed items such as unpublished working
papers. The inability to retrieve some items means that
we have been unable to include some potentially rele-
vant material in our mapping, limiting its breadth.
Conclusions
Although the epidemiologic pattern of diabetes may dif-
fer according to the stage of health transition that a
country is going through, the occurrence of depression
among diabetic patients or independently seems to be
associated with lower SES, through most of its variables
amenable to measurement in epidemiologic studies.
There exists an undiagnosed burden of psychiatric disor-
ders in the population, with an increased risk among
those from low socio-economic strata and the elderly.
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eity of measured socio-economic variables, there have
been some recurrent associations. Depression was more
likely to be present among the elderly, and among those
with low family income, the non-professional/administra-
tive class, those not currently employed and dependent,
those living alone and with less social support. The rela-
tionship with education has been variable by country,
showing a curvilinear gradient in the study from Syria
[44], a significant association of low levels of education
with depression in the studies from China [45,49]. Studies
have also shown a higher prevalence of depression
among women, [22,44,49,57] which could be influenced
by sociocultural roles of women in these countries,
including responsibilities at work and home, single
parenthood, childcare, psychological attributes, or poor
social support. Being married was a protective factor.
Severity and duration of diabetes along with other
comorbid conditions were more likely to be associated
with depression.
More detailed research is needed to fully understand
the relationship between SES and diabetes comorbid
with depression. More generally, our mapping shows the
need for research to address depression and diabetes to-
gether in LMICs. The size of the evidence base is out of
step with the public health burden of this comorbidity.
The proportion of the different components of SES con-
tributing to this relationship might differ by the level of
development of the economy, health systems and social
support networks in these countries, the effect of one
component mitigating the adverse effects of another.
Understanding the multifaceted nature of socio-economic
influences on health and the need to examine individual,
system-level and community level factors and their relation
to health behaviours and quality of care would be critical
to the success of efforts at prevention.
Given the current epidemiological transition in LIMCs
and with health systems struggling to cope with emer-
ging non-communicable disease needs, this study high-
lights the strong need to develop further research in the
field. This review indicates that there is some evidence
for a consistent relation between SES and depression
comorbid with diabetes, as well as with other chronic
diseases. But the evidence is not strong enough to draw
any sensible conclusions.
Most of the studies found in this mapping do not sug-
gest solutions to the issues we highlighted. Future research
could help to determine if the associations observed are
consistent across diverse populations, which would be im-
portant to devise successful interventions to reduce dis-
ease burden in the most vulnerable populations. In
addition, efficient social support could attenuate depres-
sive symptoms in geriatric populations, in communities,
and in particular, among diabetic patients.However, we must bear in mind that social support is
not always guaranteed for people with chronic condi-
tions, especially in low income communities [67,68]; and
especially when the symptoms of uncontrolled diabetes
may evoke stigma [67]. We must also consider the fact
that the presence of depression may exacerbate negative
family and social responses to mental distress and men-
tal illness such as neglect and abandonment [69].
In several low and middle income countries where
there is limited access to specialty mental health ser-
vices, as well as an associated stigma for utilizing these
services, integrating these services with primary care
providers by offering them training and support to treat
depression would be an effective and efficient way of re-
source utilization. Furthermore, LICs are limited in their
ability to offer appropriate NCD care at the primary care
level because of socio-economic barriers, lack of insur-
ance coverage, uncoordinated care, and shortage of phy-
sicians and specialist health workers. This is further
limited by the lack of recognition of depression in many
settings. Task shifting (of primary care duties from phy-
sicians to non-physician health care providers for man-
agement of chronic diseases) has worked for the
provision of hypertension, diabetes and cardiovascular
disease care in some LICs [70,71]. Its application, par-
ticularly at community level with community health
nurses or lay health volunteers/workers may offer the
best approach to reach individuals with co-morbid dia-
betes and depression.
Endnotes
aType 1 diabetes (previously known as insulin-dependent
or childhood-onset diabetes) is characterized by a lack of
insulin production. Type 2 diabetes (formerly called non-
insulin-dependent or adult-onset diabetes) is caused by the
body’s ineffective use of insulin. It often results from excess
body weight and physical inactivity. (http://www.who.int/
topics/diabetes_mellitus/en/).
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